snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Your CSV is on the way

We’ve sent your CSV file to
send file

Provide your business email

To complete this action, please provide your Business email.

Verify your business email

You only need to verify it once.
We’ve sent a verification link to

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    disclaimer-icon
    Summary generated by AI
    Read article
    snackbar-icon
    title
    message
    Search Startups

    Molecules technology, Medium/Large Startups

    Filters
    Clear

    Search by tag 

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology (1)

    Funding Stage 

    Founded 

    From
    To

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models 

    Product Stage 

    Employees (2)

    Location 

    Status (2)
    Processing your search... This may take a moment
    12 Startups 3 In the News 4 Recently Updated
    • Total Funding
      $764.09M
      Raised
      39
      Events
    • Private Funding
      $276.19M
      Raised
      21
      Rounds
    • Public Offerings
      $487.9M
      Raised
      17
      Offerings
    • M&A
      $0
      Raised
      1
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    PolyPid logo

    PolyPid

    Public
    Polymer Lipid Encapsulation Technology
    2008 B2B2C, B2C 51-200 Public $239.24M
    orthopedics
    dental
    drug-delivery
    pharma-companies
    sustained-release
    therapeutics
    pain-relief
    cancer
    biopharmaceutical
    surgeons
    MediWound logo

    MediWound

    Public
    Enzymatic Therapeutics for Non-Surgical Tissue Repair
    2000 B2B2C 51-200 Public $206.5M
    tissue-regeneration
    dermatology
    burns
    biotechnology
    topical-treatment
    patients
    pharma-companies
    pharmaceuticals
    Protalix BioTherapeutics logo

    Protalix BioTherapeutics

    Public
    Plant-based Proteins with Improved Therapeutic Profiles
    1994 B2B 51-200 Public $159.9M
    antibodies
    oral-drugs
    pharmaceuticals
    proteins
    genetic-disorders
    plant-protein
    inflammatory-diseases
    pharma-companies
    drug-development
    Amai Proteins logo

    Amai Proteins

    Sweet Designer Proteins as a Sugar Substitute
    2016 B2B, B2B2C, B2C 51-200 A $22.82M
    climate-tech
    low-sugar-foods
    healthcare
    bioinformatics
    foodtech
    food-and-beverage
    novel-ingredients
    food-ingredients
    nutrition
    alternative-protein
    cloud-based
    biotechnology
    Anima Biotech logo

    Anima Biotech

    Small-molecule mRNA Drug Discovery
    2014 B2B 51-200 Seed $30M
    immunology
    drug-discovery
    biotechnology
    neurology
    cancer
    biopharmaceutical
    proteins
    pharmaceuticals
    artificial-intelligence
    oncology
    neuroscience
    pharma-companies
    patent-pending
    Biolojic Design logo

    Biolojic Design

    Human Antibody Therapeutics
    2010 B2B 51-200 Seed $3.95M
    bioconvergence
    therapeutics
    bioinformatics
    decision-support
    nanotechnology
    robotics
    digital-healthcare
    drug-discovery
    immunology
    healthcare
    cancer-therapy
    antibodies
    artificial-intelligence
    pharma-companies
    Dexcel Pharma logo

    Dexcel Pharma

    New Formulations of Known Molecules and Complex Generic Drugs
    1965 B2B, B2C 500+ Mature Undisclosed
    sustained-release
    generic-drugs
    pharmaceuticals
    drug-discovery
    nanotechnology
    pharma-companies
    drug-delivery
    patients
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    12 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $764.09M
      Raised
      39
      Events
    • Private Funding
      $276.19M
      Raised
      21
      Rounds
    • Public Offerings
      $487.9M
      Raised
      17
      Offerings
    • M&A
      $0
      Raised
      1
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    PolyPid logo
    Raised
    $239.24M
    PolyPid
    Public
    Polymer Lipid Encapsulation Technology
    Founded:2008
    Business Model:B2B2C, B2C
    Employees:51-200
    Funding Stage:Public
    MediWound logo
    Raised
    $206.5M
    MediWound
    Public
    Enzymatic Therapeutics for Non-Surgical Tissue Repair
    Founded:2000
    Business Model:B2B2C
    Employees:51-200
    Funding Stage:Public
    Protalix BioTherapeutics logo
    Raised
    $159.9M
    Protalix BioTherapeutics
    Public
    Plant-based Proteins with Improved Therapeutic Profiles
    Founded:1994
    Business Model:B2B
    Employees:51-200
    Funding Stage:Public
    Amai Proteins logo
    Raised
    $22.82M
    Amai Proteins
    Sweet Designer Proteins as a Sugar Substitute
    Founded:2016
    Business Model:B2B, B2B2C, B2C
    Employees:51-200
    Funding Stage:A
    Anima Biotech logo
    Raised
    $30M
    Anima Biotech
    Small-molecule mRNA Drug Discovery
    Founded:2014
    Business Model:B2B
    Employees:51-200
    Funding Stage:Seed
    Biolojic Design logo
    Raised
    $3.95M
    Biolojic Design
    Human Antibody Therapeutics
    Founded:2010
    Business Model:B2B
    Employees:51-200
    Funding Stage:Seed
    Dexcel Pharma logo
    Raised
    Undisclosed
    Dexcel Pharma
    New Formulations of Known Molecules and Complex Generic Drugs
    Founded:1965
    Business Model:B2B, B2C
    Employees:500+
    Funding Stage:Mature
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,